Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta

J Biol Chem. 2006 Nov 10;281(45):33971-81. doi: 10.1074/jbc.M607010200. Epub 2006 Sep 7.

Abstract

Metastasis is a primary cause of mortality due to cancer. Early metastatic growth involves both a remodeling of the extracellular matrix surrounding tumors and invasion of tumors across the basement membrane. Up-regulation of extracellular matrix degrading proteases such as urokinase plasminogen activator (uPA) and matrix metalloproteinases has been reported to facilitate tumor cell invasion. Autocrine transforming growth factor-beta (TGF-beta) signaling may play an important role in cancer cell invasion and metastasis; however, the underlying mechanisms remain unclear. In the present study, we report that autocrine TGF-beta supports cancer cell invasion by maintaining uPA levels through protein secretion. Interestingly, treatment of paracrine/exogenous TGF-beta at higher concentrations than autocrine TGF-beta further enhanced uPA expression and cell invasion. The enhanced uPA expression by exogenous TGF-beta is a result of increased uPA mRNA expression due to RNA stabilization. We observed that both autocrine and paracrine TGF-beta-mediated regulation of uPA levels was lost upon depletion of Smad4 protein by RNA interference. Thus, through the Smad pathway, autocrine TGF-beta maintains uPA expression through facilitated protein secretion, thereby supporting tumor cell invasiveness, whereas exogenous TGF-beta further enhances uPA expression through mRNA stabilization leading to even greater invasiveness of the cancer cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Autocrine Communication*
  • Blotting, Northern
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Cell Membrane / metabolism
  • Cell Proliferation
  • Collagen
  • Drug Combinations
  • Female
  • Genes, Dominant
  • Humans
  • Immunoblotting
  • Laminin
  • Matrix Metalloproteinase 9 / metabolism
  • Neoplasm Invasiveness
  • Paracrine Communication*
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Proteoglycans
  • RNA Stability*
  • Receptors, Transforming Growth Factor beta / genetics
  • Receptors, Transforming Growth Factor beta / metabolism
  • Smad4 Protein / metabolism*
  • Transforming Growth Factor beta / pharmacology*
  • Tumor Cells, Cultured
  • Urokinase-Type Plasminogen Activator / metabolism*

Substances

  • Drug Combinations
  • Laminin
  • Plasminogen Activator Inhibitor 1
  • Proteoglycans
  • Receptors, Transforming Growth Factor beta
  • SMAD4 protein, human
  • Smad4 Protein
  • Transforming Growth Factor beta
  • matrigel
  • Collagen
  • Urokinase-Type Plasminogen Activator
  • Matrix Metalloproteinase 9